Last updated 2026-06-18
- Raised funding round, Dec 2023
- Raised funding round, Sep 2022
Total raised
—
Last: 2023-12
Stage
Seed
Founded
2021
Headcount
8
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences
About
Trojan Bio is a preclinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of cancers. The company’s Trojan antibodies integrate viral peptides to efficiently activate the immune system for cancer eradication.
Trojan Bio specific antibody is composed of 2 modules - Cancer targeting module and a Viral immunity activation module. It targets cancer cells and label them as virally infected cells. The company is harnessing the powerful anti-viral immunity to fight a variety of cancers.
Funding history · 2 rounds · — total
2023-12
Undisclosed
2022-09
Undisclosed
Q&A
- What is Trojan Bio's primary focus?
- Trojan Bio is a preclinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of various cancers. Their Trojan antibodies integrate viral peptides to activate the immune system for cancer eradication.
- When was Trojan Bio founded?
- Trojan Bio was founded in October 2021.
- How many employees does Trojan Bio have?
- Trojan Bio has 1-10 employees.
- Where is Trojan Bio headquartered?
- Trojan Bio is headquartered in Yavne, Israel.
- Which investors participated in Trojan Bio's funding round in December 2023?
- Peregrine Ventures participated in Trojan Bio's funding round in December 2023.
- Which investor participated in Trojan Bio's funding round in September 2022?
- NFX Capital participated in Trojan Bio's funding round in September 2022.
- What is Trojan Bio's current funding stage?
- Trojan Bio is currently in the Seed funding stage.
- What is the product stage of Trojan Bio's offerings?
- Trojan Bio's product is in the clinical trial stage.
Team · 3
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
cancerclinicspharmaceuticalsimmuno-theraphycancer-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | trojan-bio.com/ |
|---|---|
| linkedin.com/company/82642561 |
Identifiers & details
| Founded | 2021-10 |
|---|---|
| Employees (exact) | 8 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | trojan-bio.com |
|---|